APA (7th ed.) Citation

Kennedy, S. A., Morrissey, M. E., Dunne, M. R., O'Connell, F., Butler, C. T., Cathcart, M., . . . O'Sullivan, J. (2020). Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors. BMC Cancer, 20(1), 1. https://doi.org/10.1186/s12885-020-07430-y

Chicago Style (17th ed.) Citation

Kennedy, Susan A., et al. "Combining 1,4-dihydroxy Quininib with Bevacizumab/FOLFOX Alters Angiogenic and Inflammatory Secretions in Ex Vivo Colorectal Tumors." BMC Cancer 20, no. 1 (2020): 1. https://doi.org/10.1186/s12885-020-07430-y.

MLA (9th ed.) Citation

Kennedy, Susan A., et al. "Combining 1,4-dihydroxy Quininib with Bevacizumab/FOLFOX Alters Angiogenic and Inflammatory Secretions in Ex Vivo Colorectal Tumors." BMC Cancer, vol. 20, no. 1, 2020, p. 1, https://doi.org/10.1186/s12885-020-07430-y.